11th stakeholder forum on the pharmacovigilance legislation
Date:
21/09/2017
Location:
European Medicines Agency, London, UK
This forum brings together regulators with patients, healthcare professionals and industry, to take stock of what we have achieved and what needs to be the focus over the coming years.
-
List item
Agenda – Eleventh stakeholder forum on the pharmacovigilance legislation (PDF/87.45 KB)
Adopted
First published: 25/08/2017
Last updated: 28/09/2017
EMA/303132/2017 -
List item
Presentation - Future opportunities for pharmacovigilance (à. Spooner, HPRA and PRAC) (PDF/1.66 MB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - How patients and healthcare professionals can be involved in public hearings (J. Garcia Burgos, EMA) (PDF/1.9 MB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - Pharmacovigilance Risk Assessment Committee - Five years of operation (J. Raine, PRAC) (PDF/2.91 MB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - Strengthening collaborations for operating pharmacovigilance in Europe Joint Action (L. Loughlin, MHRA) (PDF/4.14 MB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - EudraVigilance – new functionalities and EudraVigilance access policy (patient access) (S. Brosch, EMA) (PDF/393.06 KB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - Patient Registries Initiative Lessons learned from the recent workshops (X. Kurz, EMA) (PDF/484.69 KB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - Signal management process (G. Genov, EMA) (PDF/576.77 KB)
First published: 28/09/2017
Last updated: 28/09/2017 -
List item
Presentation - Learnings & next steps for EMSP as initiator and driver (C.Thalheim, J.Hlavacova) (PDF/677.74 KB)
First published: 28/09/2017
Last updated: 28/09/2017